| Product Code: ETC7645277 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Asthma and COPD Drug Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Asthma and COPD Drug Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Asthma and COPD Drug Market - Industry Life Cycle |
3.4 Israel Asthma and COPD Drug Market - Porter's Five Forces |
3.5 Israel Asthma and COPD Drug Market Revenues & Volume Share, By Diseses, 2021 & 2031F |
3.6 Israel Asthma and COPD Drug Market Revenues & Volume Share, By Medication Class, 2021 & 2031F |
4 Israel Asthma and COPD Drug Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of asthma and COPD in Israel |
4.2.2 Growing awareness about respiratory diseases and available treatments |
4.2.3 Technological advancements in drug development for asthma and COPD |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval in Israel |
4.3.2 High cost of asthma and COPD medications |
4.3.3 Limited access to healthcare services in certain regions of Israel |
5 Israel Asthma and COPD Drug Market Trends |
6 Israel Asthma and COPD Drug Market, By Types |
6.1 Israel Asthma and COPD Drug Market, By Diseses |
6.1.1 Overview and Analysis |
6.1.2 Israel Asthma and COPD Drug Market Revenues & Volume, By Diseses, 2021- 2031F |
6.1.3 Israel Asthma and COPD Drug Market Revenues & Volume, By Asthma, 2021- 2031F |
6.1.4 Israel Asthma and COPD Drug Market Revenues & Volume, By COPD, 2021- 2031F |
6.2 Israel Asthma and COPD Drug Market, By Medication Class |
6.2.1 Overview and Analysis |
6.2.2 Israel Asthma and COPD Drug Market Revenues & Volume, By Combination Drugs, 2021- 2031F |
6.2.3 Israel Asthma and COPD Drug Market Revenues & Volume, By Short Acting Beta Agonists (SABA), 2021- 2031F |
6.2.4 Israel Asthma and COPD Drug Market Revenues & Volume, By Long Acting Beta Agonists (LABA), 2021- 2031F |
6.2.5 Israel Asthma and COPD Drug Market Revenues & Volume, By Leukotriene Antagonists (LTA), 2021- 2031F |
6.2.6 Israel Asthma and COPD Drug Market Revenues & Volume, By Anticholinergics, 2021- 2031F |
6.2.7 Israel Asthma and COPD Drug Market Revenues & Volume, By Others, 2021- 2031F |
7 Israel Asthma and COPD Drug Market Import-Export Trade Statistics |
7.1 Israel Asthma and COPD Drug Market Export to Major Countries |
7.2 Israel Asthma and COPD Drug Market Imports from Major Countries |
8 Israel Asthma and COPD Drug Market Key Performance Indicators |
8.1 Patient adherence rate to prescribed asthma and COPD medications |
8.2 Number of new drug approvals for asthma and COPD treatments in Israel |
8.3 Rate of hospital admissions due to asthma and COPD exacerbations |
9 Israel Asthma and COPD Drug Market - Opportunity Assessment |
9.1 Israel Asthma and COPD Drug Market Opportunity Assessment, By Diseses, 2021 & 2031F |
9.2 Israel Asthma and COPD Drug Market Opportunity Assessment, By Medication Class, 2021 & 2031F |
10 Israel Asthma and COPD Drug Market - Competitive Landscape |
10.1 Israel Asthma and COPD Drug Market Revenue Share, By Companies, 2024 |
10.2 Israel Asthma and COPD Drug Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here